Ompenaclid

Ompenaclid

SCHEMBL33761

N=C(N)NCCC(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ompenaclid SCHEMBL19825523 0.98 ECE1 (0.45)
Ompenaclid SCHEMBL29117517 0.98 ECE1 (0.45)
Ompenaclid SCHEMBL15708482 0.98 ECE1 (0.45)
Ompenaclid SCHEMBL28006896 0.98 ECE1 (0.45)
Ompenaclid SCHEMBL11796034 0.98 ECE1 (0.45)
Ompenaclid SCHEMBL28243940 0.89 ITGB3 (0.40)
SCHEMBL31372702 0.86 PRMT1 (0.50)
SCHEMBL33717 0.86 PRMT1 (0.50)
SCHEMBL8770888 0.84 ITGB3 (0.51)
SCHEMBL2107302 0.84 PRMT1 (0.59)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2445 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12584924-B2 Compositions and methods for diagnosing and treating chronic kidney disease SOCIETE DES PRODUITS NESTLE S.A. (CH) 2026-03-24 US claimed
US-12582667-B2 Compositions and methods to treat metastatic gastrointestinal cancer THE ROCKEFELLER UNIVERSITY (US) 2026-03-24 US claimed
US-12553134-B2 Bendable nickel plating on flexible substrates MACDERMID ENTHONE INC. (US) 2026-02-17 US claimed
EP-4679087-A1 BIOMARKER AND USE THEREOF MEIJI CO., LTD (JP) 2026-01-14 EP claimed
EP-4034084-B1 COMPOSITIONS AND METHODS FOR TREATING METASTATIC GASTROINTESTINAL CANCER UNIV ROCKEFELLER (US) 2025-11-05 EP claimed
CN-119529748-A Thermotropic super-strong adhesive 陕西师范大学 2025-02-28 CN claimed
CN-118241340-B Polylactic acid composite fiber for paper diapers and preparation method thereof 汕头市集诚妇幼用品厂有限公司 2025-01-07 CN claimed
CN-119086538-A Colorimetric sensing test paper for detecting listeria monocytogenes through metabolic biomarkers, preparation method and application 南开大学 2024-12-06 CN claimed
WO-2024190663-A1 BIOMARKER AND USE THEREOF 株式会社明治 2024-09-19 WO claimed
CN-118530263-A Preparation method and application of mononuclear copper coordination compound 华中师范大学 2024-08-23 CN claimed
WO-1993012781-A2 CREATINE ANALOGS HAVING ANTIVIRAL ACTIVITY AMIRA, INC. (US) 1993-07-08 WO claimed
WO-1993003724-A1 PHARMACEUTICAL COMPOSITION CONTAINING 3-GUANIDINOPROPIONIC ACID AND PIOGLITAZONE GLIBENCLAMIDE OR GLIMEPIRIDE THE UPJOHN COMPANY (US) 1993-03-04 WO claimed
WO-1993000108-A1 NOVEL INHIBITORS OF PLATELET AGGREGATION CORVAS INTERNATIONAL, INC. (US) 1993-01-07 WO claimed
EP-0517820-A1 USE OF 3-GUANIDINOPROPIONIC ACID IN THE TREATMENT AND PREVENTION OF METABOLIC DISORDERS. UPJOHN CO (US) 1992-12-16 EP claimed
US-5134164-A Metabolic disorders, antiglycemic agents THE UPJOHN COMPANY (US) 1992-07-28 US claimed
US-5132324-A USE OF 3-GUANIDINOPROPIONIC ACID IN THE TREATMENT OF NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM) THE UPJOHN COMPANY (US) 1992-07-21 US claimed
WO-1991012799-A1 USE OF 3-GUANIDINOPROPIONIC ACID IN THE TREATMENT AND PREVENTION OF METABOLIC DISORDERS THE UPJOHN COMPANY (US) 1991-09-05 WO claimed
WO-1991012800-A1 USE OF 3-GUANIDINOPROPIONIC ACID IN THE TREATMENT AND PREVENTION OF METABOLIC DISORDERS THE UPJOHN COMPANY (US) 1991-09-05 WO claimed
US-5030728-A Cyclic compounds for forming complexes with urea, guanidine and amidine derivatives THE RESEARCH FOUNDATION STATE UNIVERSITY OF NEW YORK (US) 1991-07-09 US claimed
EP-0426100-A1 Stabilized enzyme compositions ABBOTT LABORATORIES (US) 1991-05-08 EP claimed